0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Smoking Cessation, and Others), Product (Software and Devices), and Sales Channel (Business-to-business [B2B] and Business-to-consumers [B2C]): Global Opportunity Analysis and Industry Forecast, 2017 - 2025
Published Date: November 2019
|
Report Code: ALLI-Auto-4F289
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
 Digital Therapeutics Market by Application Diabetes Obesity Cardiovascular Diseases CVD Central Nervous System CNS Disease Gastrointestinal Disorders GID Respiratory Diseases Smoking Cessation and Others Product Software and Devices and Sales Channel Business to business B2B and Business to consumers B2C Global Opportunity Analysis and Industry Forecast 2017 2025

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Smoking Cessation, and Others), Product (Software and Devices), and Sales Channel (Business-to-business [B2B] and Business-to-consumers [B2C]): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

Code: ALLI-Auto-4F289
Report
November 2019
225 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

The global digital therapeutics market size was valued at USD 2.24 Billion in 2018 and is expected to reach USD 9.64 Billion by 2026 with a CAGR of 19.9% during the forecast period.

Digital therapeutics is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes for patients. For instance, digital therapeutics does not include consumer health-oriented technologies such as step-counters and calorie-counters. It’s a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. In addition, it utilizes digital health technologies to treat a psychological condition. Hence, these aforementioned factors help in increasing the global digital therapeutics market share across the world. 

The demand for global digital therapeutics is increasing due to increase in adoption of smartphones and tablets, coupled with healthcare apps; growth in need to control healthcare costs; and rise in incidence of chronic diseases. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the digital therapeutics market growth. On the contrary, high growth opportunities in untapped markets are expected to provide significant profitable opportunities for manufacturers in the digital therapeutics industry.

Application Segment Review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period. This is attributed to increasing number of overweight populations thereby, increasing number of chronic diseases due to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing the prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Product Segment Review

Depending on the product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use the existing software and develop new and advanced features, to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Region Segment Review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Key Companies:

  • 2MORROW, Inc.,
  • Fitbit, Inc. (Twine Health, Inc.),
  • Livongo Health, Inc.,
  • Medtronic Plc.,
  • Omada Health, Inc.,
  • Pear Therapeutics, Inc.,
  • Proteus Digital Health, Inc.,
  • Resmed, Inc. (Propeller Health),
  • Voluntis, Inc.,
  • Welldoc, Inc. 

The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.

Key Benefits for Stakeholders:

  • This report provides a detailed quantitative analysis of the current digital therapeutics market trends and forecast estimations from 2018 to 2026, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2026, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global digital therapeutics market.

Digital Therapeutics Key market segments :

By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product

  • Software
  • Device

By Sales Channel

Business-to-business (B2B)

  • Employer
  • Healthcare Provider
  • Others.

Business-to-consumer (B2C)

  • Patient
  • Caregiver.

By Region

  • APAC
  • Europe
  • North America
  • LAME
CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2017
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns
3.4.3. Opportunity
3.4.3.1. Emerging markets offer significant growth opportunities
CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diabetes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Obesity
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Cardiovascular diseases
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Central nervous system (cns) diseases
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Gastrointestinal disorder
4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Respiratory diseases
4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Smoking cessation
4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Others
4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Software
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Business-To-Business (b2b)
6.2.1. Market size and forecast, by type
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Employer
6.2.4.1. Market size and forecast
6.2.5. Healthcare Providers
6.2.5.1. Market size and forecast
6.2.6. Others
6.2.6.1. Market size and forecast
6.3. Business-to-consumers
6.3.1. Market size and forecast, by type
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Patients
6.3.4.1. Market size and forecast
6.3.5. Caregivers
6.3.5.1. Market size and forecast
CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North america
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country
7.2.2.1. U.S. digital therapeutics market by application
7.2.2.2. U.S digital therapeutics market by product type
7.2.2.3. U.S. digital therapeutics market by sales channel
7.2.2.4. Canada digital therapeutics market by application
7.2.2.5. Canada digital therapeutics market by product type
7.2.2.6. Canada digital therapeutics market by sales channel
7.2.2.7. Mexico digital therapeutics market by application
7.2.2.8. Mexico digital therapeutics market by product type
7.2.2.9. Mexico digital therapeutics market by sales channel
7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country
7.3.2.1. UK digital therapeutics market by application
7.3.2.2. UK digital therapeutics market by product type
7.3.2.3. UK digital therapeutics market by sales channel
7.3.2.4. Germany digital therapeutics market by application
7.3.2.5. Germany digital therapeutics market by product type
7.3.2.6. Germany digital therapeutics market by sales channel
7.3.2.7. France digital therapeutics market by application
7.3.2.8. France digital therapeutics market by product type
7.3.2.9. France digital therapeutics market by sales channel
7.3.2.10. Italy digital therapeutics market by application
7.3.2.11. Italy digital therapeutics market by product type
7.3.2.12. Italy digital therapeutics market by sales channel
7.3.2.13. Spain digital therapeutics market by application
7.3.2.14. Spain digital therapeutics market by product type
7.3.2.15. Spain digital therapeutics market by sales channel
7.3.2.16. Rest of Europe digital therapeutics market by application
7.3.2.17. Rest of Europe digital therapeutics market by product type
7.3.2.18. Rest of Europe digital therapeutics market by sales channel
7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country
7.4.2.1. Japan digital therapeutics market by application
7.4.2.2. Japan digital therapeutics market by product type
7.4.2.3. Japan digital therapeutics market by sales channel
7.4.2.4. China digital therapeutics market by application
7.4.2.5. China digital therapeutics market by product type
7.4.2.6. China digital therapeutics market by sales channel
7.4.2.7. Australia digital therapeutics market by application
7.4.2.8. Australia digital therapeutics market by product type
7.4.2.9. Australia digital therapeutics market by sales channel
7.4.2.10. India digital therapeutics market by application
7.4.2.11. India digital therapeutics market by product type
7.4.2.12. India digital therapeutics market by sales channel
7.4.2.13. South Korea digital therapeutics market by application
7.4.2.14. South Korea digital therapeutics market by product type
7.4.2.15. South Korea digital therapeutics market by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel
7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country
7.5.2.1. Brazil digital therapeutics market by application
7.5.2.2. Brazil digital therapeutics market by product type
7.5.2.3. Brazil digital therapeutics market by sales channel
7.5.2.4. Turkey digital therapeutics market by application
7.5.2.5. Turkey digital therapeutics market by product type
7.5.2.6. Turkey digital therapeutics market by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market by application
7.5.2.8. Saudi Arabia digital therapeutics market by product type
7.5.2.9. Saudi Arabia digital therapeutics market by sales channel
7.5.2.10. South Africa digital therapeutics market by application
7.5.2.11. South Africa digital therapeutics market by product type
7.5.2.12. South Africa digital therapeutics market by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market by application
7.5.2.14. Rest of LAMEA digital therapeutics market by product type
7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel
7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel
CHAPTER 8: COMPANY PROFILES
8.1. PROTEUS DIGITAL HEALTH, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. OMADA HEALTH, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. WELLDOC, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Key strategic moves and developments
8.4. 2 MORROW INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. LIVONGO HEALTH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. PROPELLER HEALTH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. TWINE HEALTH, INC. (FITBIT INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. CANARY HEALTH, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NOOM INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. MEDTRONIC PLC
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and development
TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 20172025 ($MILLION)

TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 20172025 ($MILLION)

TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET

TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 20172025 ($MILLION)

TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 20172025 ($MILLION)

TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)

TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 20172025 ($MILLION)

TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS

TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 20172025 ($MILLION)

TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 20172025 ($MILLION)

TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)

TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)

TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 97. PROTEUS: COMPANY SNAPSHOT

TABLE 98. PROTEUS: PRODUCT PORTFOLIO

TABLE 99. OMADA: COMPANY SNAPSHOT

TABLE 100. WELLDOC: COMPANY SNAPSHOT

TABLE 101. 2MORROW: COMPANY SNAPSHOT

TABLE 102. LIVONGO: COMPANY SNAPSHOT

TABLE 103. LIVONGO: PRODUCT PORTFOLIO

TABLE 104. PROPELLER: COMPANY SNAPSHOT

TABLE 105. TWINE: COMPANY SNAPSHOT

TABLE 106. CANARY: COMPANY SNAPSHOT

TABLE 107. CANARY: PRODUCT PORTFOLIO

TABLE 108. NOOM: COMPANY SNAPSHOT

TABLE 109. MEDTRONIC: COMPANY SNAPSHOT

TABLE 110. MEDTRONIC: OPERATING SEGMENTS

TABLE 111. MEDTRONIC: PRODUCT PORTFOLIO FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS IN DIGITAL THERAPEUTICSS MARKET, 2017

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*

FIGURE 06. TOP PLAYER POSITIONING, 2017

FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 08. HIGH BARGAINING POWER OF BUYERS

FIGURE 09. LOW THREAT OF SUBSTITUTION

FIGURE 10. MODERATE THREAT OF NEW ENTRANT

FIGURE 11. MODERATE COMPETITIVE RIVALRY

FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY

FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION

FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES , BY COUNTRY, 2017 & 2025, 2023 ($MILLION)

FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2017 & 2024 (%)

FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL

FIGURE 26. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 20172025 ($MILLION)

FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 20172025 ($MILLION)

FIGURE 29. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 20172025 ($MILLION)

FIGURE 30. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 20172025 ($MILLION)

FIGURE 32. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 20172025 ($MILLION)

FIGURE 33. MEDTRONIC, 20152017 ($MILLION)

FIGURE 34. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 35. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%

The global digital therapeutics market size was valued at USD 2.24 Billion in 2018 and is expected to reach USD 9.64 Billion by 2026 with a CAGR of 19.9% during the forecast period.

Digital therapeutics is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes for patients. For instance, digital therapeutics does not include consumer health-oriented technologies such as step-counters and calorie-counters. It’s a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. In addition, it utilizes digital health technologies to treat a psychological condition. Hence, these aforementioned factors help in increasing the global digital therapeutics market share across the world. 

The demand for global digital therapeutics is increasing due to increase in adoption of smartphones and tablets, coupled with healthcare apps; growth in need to control healthcare costs; and rise in incidence of chronic diseases. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the digital therapeutics market growth. On the contrary, high growth opportunities in untapped markets are expected to provide significant profitable opportunities for manufacturers in the digital therapeutics industry.

Application Segment Review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period. This is attributed to increasing number of overweight populations thereby, increasing number of chronic diseases due to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing the prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Product Segment Review

Depending on the product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use the existing software and develop new and advanced features, to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Region Segment Review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2018, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

Key Companies:

  • 2MORROW, Inc.,
  • Fitbit, Inc. (Twine Health, Inc.),
  • Livongo Health, Inc.,
  • Medtronic Plc.,
  • Omada Health, Inc.,
  • Pear Therapeutics, Inc.,
  • Proteus Digital Health, Inc.,
  • Resmed, Inc. (Propeller Health),
  • Voluntis, Inc.,
  • Welldoc, Inc. 

The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.

Key Benefits for Stakeholders:

  • This report provides a detailed quantitative analysis of the current digital therapeutics market trends and forecast estimations from 2018 to 2026, which assists to identify the prevailing market opportunities. 
  • An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future market potential from 2019 to 2026, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global digital therapeutics market.

Digital Therapeutics Key market segments :

By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product

  • Software
  • Device

By Sales Channel

Business-to-business (B2B)

  • Employer
  • Healthcare Provider
  • Others.

Business-to-consumer (B2C)

  • Patient
  • Caregiver.

By Region

  • APAC
  • Europe
  • North America
  • LAME
Read More
CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2017
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns
3.4.3. Opportunity
3.4.3.1. Emerging markets offer significant growth opportunities
CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diabetes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Obesity
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Cardiovascular diseases
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Central nervous system (cns) diseases
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Gastrointestinal disorder
4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Respiratory diseases
4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Smoking cessation
4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Others
4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Software
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Business-To-Business (b2b)
6.2.1. Market size and forecast, by type
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Employer
6.2.4.1. Market size and forecast
6.2.5. Healthcare Providers
6.2.5.1. Market size and forecast
6.2.6. Others
6.2.6.1. Market size and forecast
6.3. Business-to-consumers
6.3.1. Market size and forecast, by type
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Patients
6.3.4.1. Market size and forecast
6.3.5. Caregivers
6.3.5.1. Market size and forecast
CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North america
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country
7.2.2.1. U.S. digital therapeutics market by application
7.2.2.2. U.S digital therapeutics market by product type
7.2.2.3. U.S. digital therapeutics market by sales channel
7.2.2.4. Canada digital therapeutics market by application
7.2.2.5. Canada digital therapeutics market by product type
7.2.2.6. Canada digital therapeutics market by sales channel
7.2.2.7. Mexico digital therapeutics market by application
7.2.2.8. Mexico digital therapeutics market by product type
7.2.2.9. Mexico digital therapeutics market by sales channel
7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country
7.3.2.1. UK digital therapeutics market by application
7.3.2.2. UK digital therapeutics market by product type
7.3.2.3. UK digital therapeutics market by sales channel
7.3.2.4. Germany digital therapeutics market by application
7.3.2.5. Germany digital therapeutics market by product type
7.3.2.6. Germany digital therapeutics market by sales channel
7.3.2.7. France digital therapeutics market by application
7.3.2.8. France digital therapeutics market by product type
7.3.2.9. France digital therapeutics market by sales channel
7.3.2.10. Italy digital therapeutics market by application
7.3.2.11. Italy digital therapeutics market by product type
7.3.2.12. Italy digital therapeutics market by sales channel
7.3.2.13. Spain digital therapeutics market by application
7.3.2.14. Spain digital therapeutics market by product type
7.3.2.15. Spain digital therapeutics market by sales channel
7.3.2.16. Rest of Europe digital therapeutics market by application
7.3.2.17. Rest of Europe digital therapeutics market by product type
7.3.2.18. Rest of Europe digital therapeutics market by sales channel
7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country
7.4.2.1. Japan digital therapeutics market by application
7.4.2.2. Japan digital therapeutics market by product type
7.4.2.3. Japan digital therapeutics market by sales channel
7.4.2.4. China digital therapeutics market by application
7.4.2.5. China digital therapeutics market by product type
7.4.2.6. China digital therapeutics market by sales channel
7.4.2.7. Australia digital therapeutics market by application
7.4.2.8. Australia digital therapeutics market by product type
7.4.2.9. Australia digital therapeutics market by sales channel
7.4.2.10. India digital therapeutics market by application
7.4.2.11. India digital therapeutics market by product type
7.4.2.12. India digital therapeutics market by sales channel
7.4.2.13. South Korea digital therapeutics market by application
7.4.2.14. South Korea digital therapeutics market by product type
7.4.2.15. South Korea digital therapeutics market by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel
7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country
7.5.2.1. Brazil digital therapeutics market by application
7.5.2.2. Brazil digital therapeutics market by product type
7.5.2.3. Brazil digital therapeutics market by sales channel
7.5.2.4. Turkey digital therapeutics market by application
7.5.2.5. Turkey digital therapeutics market by product type
7.5.2.6. Turkey digital therapeutics market by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market by application
7.5.2.8. Saudi Arabia digital therapeutics market by product type
7.5.2.9. Saudi Arabia digital therapeutics market by sales channel
7.5.2.10. South Africa digital therapeutics market by application
7.5.2.11. South Africa digital therapeutics market by product type
7.5.2.12. South Africa digital therapeutics market by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market by application
7.5.2.14. Rest of LAMEA digital therapeutics market by product type
7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel
7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel
CHAPTER 8: COMPANY PROFILES
8.1. PROTEUS DIGITAL HEALTH, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. OMADA HEALTH, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. WELLDOC, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Key strategic moves and developments
8.4. 2 MORROW INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. LIVONGO HEALTH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. PROPELLER HEALTH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. TWINE HEALTH, INC. (FITBIT INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. CANARY HEALTH, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NOOM INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. MEDTRONIC PLC
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and development
Read More
TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 20172025 ($MILLION)

TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 20172025 ($MILLION)

TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 20172025 ($MILLION)

TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET

TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 20172025 ($MILLION)

TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 20172025 ($MILLION)

TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 20172025 ($MILLION)

TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)

TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 20172025 ($MILLION)

TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS

TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 20172025 ($MILLION)

TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 20172025 ($MILLION)

TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)

TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)

TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 20172025 ($MILLION)

TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)

TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)

TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)

TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)

TABLE 97. PROTEUS: COMPANY SNAPSHOT

TABLE 98. PROTEUS: PRODUCT PORTFOLIO

TABLE 99. OMADA: COMPANY SNAPSHOT

TABLE 100. WELLDOC: COMPANY SNAPSHOT

TABLE 101. 2MORROW: COMPANY SNAPSHOT

TABLE 102. LIVONGO: COMPANY SNAPSHOT

TABLE 103. LIVONGO: PRODUCT PORTFOLIO

TABLE 104. PROPELLER: COMPANY SNAPSHOT

TABLE 105. TWINE: COMPANY SNAPSHOT

TABLE 106. CANARY: COMPANY SNAPSHOT

TABLE 107. CANARY: PRODUCT PORTFOLIO

TABLE 108. NOOM: COMPANY SNAPSHOT

TABLE 109. MEDTRONIC: COMPANY SNAPSHOT

TABLE 110. MEDTRONIC: OPERATING SEGMENTS

TABLE 111. MEDTRONIC: PRODUCT PORTFOLIO FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS IN DIGITAL THERAPEUTICSS MARKET, 2017

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*

FIGURE 06. TOP PLAYER POSITIONING, 2017

FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 08. HIGH BARGAINING POWER OF BUYERS

FIGURE 09. LOW THREAT OF SUBSTITUTION

FIGURE 10. MODERATE THREAT OF NEW ENTRANT

FIGURE 11. MODERATE COMPETITIVE RIVALRY

FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY

FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION

FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES , BY COUNTRY, 2017 & 2025, 2023 ($MILLION)

FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2017 & 2024 (%)

FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL

FIGURE 26. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 20172025 ($MILLION)

FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 20172025 ($MILLION)

FIGURE 29. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 20172025 ($MILLION)

FIGURE 30. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2017-2025 ($MILLION)

FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 20172025 ($MILLION)

FIGURE 32. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 20172025 ($MILLION)

FIGURE 33. MEDTRONIC, 20152017 ($MILLION)

FIGURE 34. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 35. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$5370
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$6450
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$8995
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Clear Glass Vial Market Research Report 2020
Global Clear Glass Vial Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-17U3509
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Aminoguanidine Bicarbonate Market Research Report 2020
Global Aminoguanidine Bicarbonate Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-37F3227
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Pharmaceutical Amber Glass Bottles Market Research Report 2020
Global Pharmaceutical Amber Glass Bottles Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-22D3270
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Boron Tribromide Market Research Report 2020
Global Boron Tribromide Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-31N3242
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0